Forbion exceeds target with €270 million first close of its fourth life sciences VC fund

Forbion exceeds target with €270 million first close of its fourth life sciences VC fund

Naarden, The Netherlands, and Munich, Germany, 11 July 2018 – Forbion, a leading European life science venture capital firm, has today announced the first close of its fourth flagship fund Forbion IV, at € 270 million, exceeding the € 250 million target size.

Please click here to read full pressrelease